Annual report pursuant to Section 13 and 15(d)

Stock Compensation Plans

v2.4.0.8
Stock Compensation Plans
12 Months Ended
Mar. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Compensation Plans

Note 12 — Stock Compensation Plans:

The Amended and Restated 2000 Graham Corporation Incentive Plan to Increase Shareholder Value provides for the issuance of up to 1,375 shares of common stock in connection with grants of incentive stock options, non-qualified stock options, stock awards and performance awards to officers, key employees and outside directors; provided, however, that no more than 250 shares of common stock may be used for awards other than stock options. Stock options may be granted at prices not less than the fair market value at the date of grant and expire no later than ten years after the date of grant.

During fiscal 2013 and fiscal 2012, 49 and 9 stock options, respectively, each with a term of ten years from the date of grant were awarded to officers and key employees. No stock options were awarded in fiscal 2014. The stock option awards granted in fiscal 2013 and fiscal 2012 vest 33 1/3% per year over a three-year term. The Company has elected to use the straight-line method to recognize compensation costs related to such awards.

In fiscal 2014, fiscal 2013 and fiscal 2012, 32, 26 and 32 shares, respectively, of restricted stock were awarded. Restricted shares of 14, 18 and 16 granted to officers in fiscal 2014, fiscal 2013 and fiscal 2012, respectively, vest 100% on the third anniversary of the grant date subject to the satisfaction of the performance metrics for the applicable three-year period. Restricted shares of 12 granted to officers and key employees in fiscal 2014 vest 33 1/3% per year over a three-year term. Restricted shares of 7 granted to officers in fiscal 2012 vest 50% on the second anniversary of the grant date and 50% on the fourth anniversary of the grant date. The restricted shares granted to directors of 6, 8 and 9 in fiscal 2014, fiscal 2013 and fiscal 2012, respectively, vest 100% on the anniversary of the grant date. The Company recognizes compensation cost over the period the shares vest.

During fiscal 2014, fiscal 2013, and fiscal 2012, the Company recognized $582, $524, and $556, respectively, of stock-based compensation cost related to stock option and restricted stock awards, and $205, $184 and $198, respectively, of related tax benefits.

The weighted average fair value of options granted during fiscal 2013 and fiscal 2012 was $4.97 and $9.51, respectively, using the Black-Scholes option-pricing model with the following weighted average assumptions:

 

     Year ended March 31,  
         2013             2012      

Expected life

     3 years        3 years   

Volatility

     43.17     75.86

Risk-free interest rate

     .38     .83

Dividend yield

     .38     .47

The expected life represents an estimate of the weighted average period of time that options are expected to remain outstanding given consideration to vesting schedules and the Company’s historical exercise patterns. Expected volatility is estimated based on the historical closing prices of the Company’s common stock over the expected life of the options. The risk free interest rate is estimated based on the U.S. Federal Reserve’s historical data for the maturity of nominal treasury instruments that corresponds to the expected term of the option. Expected dividend yield is based on historical trends.

The Company received cash proceeds from the exercise of stock options of $581, $83 and $386 in fiscal 2014, fiscal 2013 and fiscal 2012, respectively. In fiscal 2014, fiscal 2013 and fiscal 2012, the Company recognized a $268, $41 and $244, respectively, increase in capital in excess of par value for the income tax benefit realized upon exercise of stock options and vesting of restricted shares in excess of the tax benefit amount recognized pertaining to the fair value of stock awards treated as compensation expense.

 

The following table summarizes information about the Company’s stock option awards during fiscal 2014, fiscal 2013 and fiscal 2012:

 

     Shares
Under
Option
    Weighted
Average
Exercise
Price
     Weighted
Average Remaining
Contractual Term
     Aggregate
Intrinsic
Value
 

Outstanding at April 1, 2011

     159      $ 11.87         

Granted

     9        21.19         

Exercised

     (50     7.72         

Expired

     (3     30.88         

Forfeited

     (1     18.09         
  

 

 

         

Outstanding at March 31, 2012

     114        13.90         

Granted

     49        18.65         

Exercised

     (13     6.35         

Forfeited

     (4     18.65         
  

 

 

         

Outstanding at March 31, 2013

     146        16.04         

Exercised

     (52     11.31         

Forfeited

     (1     19.15         
  

 

 

         

Outstanding at March 31, 2014

     93        18.60         6.35 years       $ 1,261   
  

 

 

         

Vested or expected to vest at March 31, 2014

     90        18.58         6.29 years         1,215   
  

 

 

         

Exercisable at March 31, 2014

     62        19.00         5.47 years         852   
  

 

 

         

The following table summarizes information about stock options outstanding at March 31, 2014:

 

Exercise Price

   Options Outstanding
at March 31, 2014
     Weighted Average
Exercise Price
     Weighted  Average
Remaining

Contractual Life (in years)
 

 $ 6.90-7.98

     9       $ 6.96         3.11   

12.52-15.25

     24         14.68         5.22   

18.65-21.19

     48         18.99         8.04   

30.88-44.50

     12         33.04         4.20   
  

 

 

       

  6.90-44.50

     93         18.60         6.35   
  

 

 

       

The total intrinsic value of the stock options exercised during fiscal 2014, fiscal 2013 and fiscal 2012 was $1,221, $203 and $776, respectively. As of March 31, 2014, there was $1,000 of total unrecognized stock-based compensation expense related to non-vested stock options and restricted stock. The Company expects to recognize this expense over a weighted average period of 1.47 years.

The outstanding options expire between June 2016 and May 2022. Options, stock awards and performance awards available for future grants were 423 at March 31, 2014.

 

The following table summarizes information about the Company’s restricted stock awards during fiscal 2014, fiscal 2013 and fiscal 2012:

 

     Restricted
Stock
    Weighted Average
Grant  Date Fair Value
     Aggregate
Intrinsic Value
 

Non-vested at March 31, 2011

     32      $ 15.77      

Granted

     32        20.91      

Vested

     (15     15.84      
  

 

 

      

Non-vested at March 31, 2012

     49        19.11      

Granted

     26        18.65      

Vested

     (8     22.02      

Forfeited

     (6     19.19      
  

 

 

      

Non-vested at March 31, 2013

     61        18.51      

Granted

     32        24.00      

Vested

     (24     17.20      

Forfeited

     (5     15.81      
  

 

 

      

Non-vested at March 31, 2014

     64        21.93       $ 633   
  

 

 

      

During fiscal 2014, the Company terminated its Long-Term Incentive Plan, which provided for awards of share equivalent units for outside directors based upon the Company’s performance. Upon termination, the final value of the share equivalent units was determined and the related share equivalent units were cancelled. The liability of $315 at March 31, 2014 will be paid to the participating directors in two equal installments in fiscal 2015 and fiscal 2016. Previously, under the provisions of the Long Term Incentive Plan, each unit was equivalent to one share of the Company’s common stock. Share equivalent units were credited to each outside director’s account for each of the first five full fiscal years of the director’s service when consolidated net income was at least 100% of the approved budgeted net income for the year. The share equivalent units were payable in cash or stock upon retirement. Compensation cost for share equivalent units was recorded based on the higher of the quoted market price of the Company’s stock at the end of the period up to $3.20 per unit or the stock price at date of grant. The cost of share equivalent units earned and charged to pre-tax income under this Plan was $0 in fiscal 2014, $10 in fiscal 2013 and $20 in fiscal 2012. At March 31, 2013, there were 43 share equivalent units in the Plan and the related liability recorded was $310. The expense (income) to mark to market the share equivalent units was $6, $2 and $(2) in fiscal 2014, fiscal 2013 and fiscal 2012, respectively.

The Company has an Employee Stock Purchase Plan (the “ESPP”), which allows eligible employees to purchase shares of the Company’s common stock on the last day of a six-month offering period at a purchase price equal to the lesser of 85% of the fair market value of the common stock on either the first day or the last day of the offering period. A total of 200 shares of common stock may be purchased under the ESPP. In fiscal 2014, fiscal 2013 and fiscal 2012, 16, 19 and 19 shares, respectively, were issued from treasury stock to the ESPP for the offering periods in each of the fiscal years. During fiscal 2014, fiscal 2013 and fiscal 2012, the Company recognized stock-based compensation cost of $57, $52 and $55, respectively, related to the ESPP and $20, $19 and $19, respectively, of related tax benefits. The Company recognized a $3, $2 and $3 increase in capital in excess of par value for the income tax benefit realized from disqualifying dispositions in excess of the tax benefit amount recognized pertaining to the compensation expense recorded in fiscal 2014, fiscal 2013 and fiscal 2012, respectively.